为 F. Hoffmann-La Roche 的数据分析平台提供 CONNECT 数据服务.pdf

《为 F. Hoffmann-La Roche 的数据分析平台提供 CONNECT 数据服务.pdf》由会员分享，可在线阅读，更多相关《为 F. Hoffmann-La Roche 的数据分析平台提供 CONNECT 数据服务.pdf（28页珍藏版）》请在三个皮匠报告上搜索。

1、CONNECT data services for a data analytics platform at F.Hoffmann-La RocheBernd Sessler-Senior Automation Engineer,F.Hoffman-La RocheLukas Markwalder-Director,Capgemini Digital Manufacturing Hans-Otto Weinhold-Principal Solutions Architect,AVEVAAPRIL 9,2025Roche focuses on innovation for peoples hea

2、lth around the world.With Pharmaceuticals and Diagnostics under one roof,we are uniquely positioned to improve care along the patient journey.CEO,Thomas Schinecker4Roche at a glanceWho we are and what we do*Unless otherwise stated,all growth rates and comparisons to the previous year are at constant

3、 exchange rates(CER;average rates 2023)and all total figures quoted are reported in CHF.*Medicines and tests that have either been developed or acquired by Roche128 yearsfounded in Basel in 18963 Nobel prizesand 44 Prix Galiensince 1974 CHF 60.5 billion*in Roche Group sales in 2024A leader in health

4、care R&D with CHF 13 billion invested in 202423 million people treated with our medicines in 202444 Roche medicines&90 diagnostics*on the WHO List of Essential Medicines&Tests100,000 dedicated employees worldwide30 billion testsconducted with our Diagnostics products in 20245Two divisions working to

5、gether to address healthcare needsThree shared priority disease areas between Diagnostics and PharmaDiagnosticsPharmaOphthalmologyInfectious Diseases1ImmunologyNeurologyOncology2Cardiovascular-metabolicDiagnostic solutionsOur productsDigital productsMedicinesThree shared priority disease areasDiagno

6、stics/Pharma shared disease areasLeader in key disease areasLeader in in-vitro diagnostics 1 Also relevant for Antimicrobial Resistance in Pharma;2 Includes Hematology in PharmaPharma&Life Sciences|Switzerland-GlobalF.Hoffmann-La Roche requires a reliable cloud-based data platform 2025 AVEVA Group L